Overview
Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension
Status:
Completed
Completed
Trial end date:
2013-04-01
2013-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the safety and tolerability of nebivolol and valsartan given as a free tablet combination in patient with stage 1 or stage 2 essential hypertension.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Forest LaboratoriesTreatments:
Hydrochlorothiazide
Nebivolol
Valsartan
Criteria
Inclusion Criteria:- Male or female outpatients of age 18 years or above
- Patients diagnosed with stage 1 or stage 2 essential hypertension
- Normal physical examination findings, electrocardiogram (ECG) results and chest x-ray;
or abnormal findings judged by the Investigator to be not clinically significant
Exclusion Criteria:
- Secondary hypertension or severe hypertension
- Clinically significant cardiovascular disease or heart failure
- A medical contraindication to discontinuing a current antihypertensive therapy
- History of Type 1 diabetes mellitus